
|Articles|September 29, 2016
Treatment Strategies for Mohs Disease
Aleksandar L. Krunic, MD, PhD, discusses tumor removal in Mohs disease during the 25th European Academy of Dermatology and Venereology Congress.
Advertisement
Aleksandar L. Krunic, MD, PhD, dermatologic surgeon and assistant professor of dermatology at University of Illinois College of Medicine, discusses which tumor types are best removed in Mohs disease, during the 25th European Academy of Dermatology and Venereology Congress,
held September 28 to October 2, in Vienna, Austria.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Interchangeability Designation to Denosumab Biosimilars Stoboclo and Osenvelt
2
Denosumab Biosimilars Conexxence and Bomyntra Receive Interchangeability Designation
3
Improving RSV Vaccine Coverage Could Prevent Thousands of Severe Cases in Older Adults
4
Because Ned Said: America’s Growing Pharmacy Deserts Are Leaving Patients High and Dry
5

















































































































































































































